New stent aims to dry up tears after eye surgery

NCT ID NCT03705000

Terminated Symptom relief Sponsor: Thomas Gardner Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a redesigned lacrimal stent, called the Slit Stent II, for people with severe tearing (epiphora) caused by a blocked tear duct. The stent has slits to allow tears to drain while it is still in place after DCR surgery. The trial planned to enroll 5 people to check safety and symptom relief, but it was terminated early.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Slit Stent II lacrimal stent (a modified medical device)
What this could lead to: If it works, this could offer a way to relieve severe tearing sooner after DCR surgery without compromising long-term results.
What could go wrong: This was a very small, early trial (only 5 participants planned) that was terminated, so results are limited. The device is a modification of an existing stent, and its safety and effectiveness are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DACRYOCYSTORHINOSTOMY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

excessive tearing familial congenital nasolacrimal duct obstruction lacrimal apparatus disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DACRYOCYSTORHINOSTOMY EPIPHORA

Contacts and locations

Locations

Kellogg Eye Center, 1000 Wall Street

Ann Arbor, Michigan, 48105, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.